Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.

Zufferey P, Dudler J, Scherer A, Finckh A.

Joint Bone Spine. 2013 Mar;80(2):160-4. doi: 10.1016/j.jbspin.2012.05.003.

PMID:
22771133
2.

Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?

Ciubotariu E, Gabay C, Finckh A; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis..

J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767.

PMID:
25028383
3.

Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.

Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X; EMECAR Study Group..

J Rheumatol. 2003 Apr;30(4):697-704.

PMID:
12672186
4.

Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A.

Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004.

PMID:
21168187
5.

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.

Gabay C, Riek M, Scherer A, Finckh A; SCQM collaborating physicians..

Rheumatology (Oxford). 2015 Sep;54(9):1664-72. doi: 10.1093/rheumatology/kev019.

PMID:
25922549
6.

Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.

Gibofsky A, Palmer WR, Goldman JA, Lautzenheiser RL, Markenson JA, Weaver A, Schiff MH, Keystone EC, Paulus HE, Harrison MJ, Whitmore JB, Leff JA.

Curr Med Res Opin. 2006 Jan;22(1):169-83.

PMID:
16393443
7.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register..

Rheumatology (Oxford). 2006 Dec;45(12):1558-65.

PMID:
16705046
8.

Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.

Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-De La Torre I, Khoury VJ, Millán A, Soriano ER; GLADAR..

J Clin Rheumatol. 2012 Oct;18(7):327-35. doi: 10.1097/RHU.0b013e31826d6610.

PMID:
23047532
9.

Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.

Bonafede MM, Fox KM, Johnson BH, Watson C, Gandra SR.

Clin Ther. 2012 Feb;34(2):457-67. doi: 10.1016/j.clinthera.2011.12.016.

PMID:
22284901
10.

Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.

Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis..

Arthritis Rheum. 2007 May 15;57(4):679-85.

11.
12.

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.

Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA; RADIUS Investigators..

Curr Med Res Opin. 2006 Jan;22(1):185-98.

PMID:
16393444
13.

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, Wassenberg S, Kapelle A, Listing J.

Arthritis Rheum. 2006 Nov;54(11):3399-407.

14.

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.

Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, Johnson DS, Sauer BC.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1680-90. doi: 10.1002/acr.20629.

15.

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.

Hetland ML, Lindegaard HM, Hansen A, Pødenphant J, Unkerskov J, Ringsdal VS, Østergaard M, Tarp U.

Ann Rheum Dis. 2008 Jul;67(7):1023-6. doi: 10.1136/ard.2007.087262.

PMID:
18272669
16.

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study.

Aaltonen KJ, Virkki LM, Jämsen E, Sokka T, Konttinen YT, Peltomaa R, Tuompo R, Yli-Kerttula T, Kortelainen S, Ahokas-Tuohinto P, Blom M, Nordström DC.

Semin Arthritis Rheum. 2013 Aug;43(1):55-62. doi: 10.1016/j.semarthrit.2013.01.002.

PMID:
23481417
17.

The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.

de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL.

Rheumatology (Oxford). 2012 Sep;51(9):1610-7. doi: 10.1093/rheumatology/kes078.

PMID:
22539487
18.

Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Osiri M, Deesomchok U, Tugwell P.

Clin Rheumatol. 2006 Sep;25(5):721-7.

PMID:
16365685
19.
20.

A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmö, Sweden, 1997-2005.

Söderlin MK, Lindroth Y, Turesson C, Jacobsson LT.

Scand J Rheumatol. 2010 May;39(3):206-11. doi: 10.3109/03009740903313621.

PMID:
20001765

Supplemental Content

Support Center